Skip to content

PHARMADIX

Active
Private limited companyfounded 20223 yrs activeKorteweg 5, 8560 Wevelgem, BelgiumKBO/BCE: BE 0794.868.478
Summary

The computed 12-month bankruptcy probability of PHARMADIX is 2.1% (moderate). The 2024 annual accounts show equity of €141,337 and a net result of €38,317. Its solvency ranks better than 84% of 26040 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
Axes · tick = 2023
Profitability94▼-6
Solvency100=
Growth52
Track record94
Bankruptcy probability, 12 months
2.1% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €11,000 at 30 days acceptable
Liquidity ample (current ratio 3.91 against 4.43 in 2023; short-term debt: 24.4% and cash: 53.2% of total assets), and 24.4% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 27-06-2025, 34 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
not confirmed
2024
34 d early
2023
22 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 6 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

PHARMADIX was incorporated on 16 December 2022 as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€141,337▲ 37.2%
2023 · €103,020
Total assets
€186,918▲ 43.4%
2023 · €130,345
Net result
€38,317▼ 58.8%
2023 · €93,020
Working capital
€132,445▲ 41.4%
2023 · €93,634
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20232024
Operating result€131,588-€58,594▼ 55.5%
Net result€93,020above the sector's middle half-€38,317above the sector's middle half▼ 58.8%
Equity€103,020within the sector's middle half-€141,337above the sector's middle half▲ 37.2%
Total assets€130,345within the sector's middle half-€186,918within the sector's middle half▲ 43.4%
Debt€27,325-€45,581▲ 66.8%
Working capital€93,634-€132,445▲ 41.4%
Solvency79.0%above the sector's middle half-75.6%above the sector's middle half▼ 3.4pp
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000€150,000Operating result 2023: €131,588€131,588Net result 2023: €93,020€93,020Operating result 2024: €58,594€58,594Net result 2024: €38,317€38,31720232024€0€50,000€100,000€150,000Operating result 2023: €131,588€132,000Net result 2023: €93,020€93,000Operating result 2024: €58,594€58,600Net result 2024: €38,317€38,30020232024
The operating result falls in 2024; 2024 is 55% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €186,918
Fixed assets €8,892 ▼ 5.3%
Current assets €178,026 ▲ 47.2%
Equity and liabilities €186,918
Equity €141,337 ▲ 37.2%
Debt €45,581 ▲ 66.8%
Debt's share of the balance-sheet total rises from 21.0% to 24.4%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€59,088▼
2023 · €132,082
Cash flow
€38,811▼
2023 · €93,514
Current ratio
3.91▼
2023 · 4.43
Quick ratio
2.69▲
2023 · 2.22
Debt to equity
0.32▲
2023 · 0.27
ROE
27.1%▼
2023 · 90.3%
ROA
20.5%▼
2023 · 71.4%
Interest coverage
235.38▲
2023 · 36.19
Debt ≤ 1 year
€45,581▲
2023 · €27,325
Income taxes
€20,202▼
2023 · €36,198
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,275 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
2.2% stopped otherwise
96% still going

A further 0.4% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 2.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,275 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 38 lines
Balance sheet Code20232024
Assets
Total assets20/58€130,345€186,918▲
Fixed assets21/28€9,386€8,892▼
Tangible fixed assets22/27€9,386€8,892▼
Plant, machinery and equipment23€9,386€8,892▼
Current assets29/58€120,959€178,026▲
Stocks and contracts in progress3€60,251€55,430▼
Stocks30/36€60,251€55,430▼
Amounts receivable within one year40/41€3,867€23,215▲
Other amounts receivable41€3,867€23,215▲
Cash at bank and in hand54/58€56,841€99,380▲
Equity and liabilities
Total equity and liabilities10/49€130,345€186,918▲
Equity10/15€103,020€141,337▲
Contributions10/11€10,000€10,000=
Reserves13€93,020€131,337▲
Distributable reserves133€93,020€131,337▲
Amounts payable17/49€27,325€45,581▲
Amounts payable within one year42/48€27,325€45,581▲
Current portion of amounts payable after more than one year42-€1,714
Trade debts44€9,927€17,467▲
Suppliers440/4€9,927€17,467▲
Taxes, remuneration and social security45€16,198€26,400▲
Taxes450/3€16,198€26,400▲
Other amounts payable47/48€1,200-
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€494€494=
Other operating charges640/8€1,816€1,818▲
Gross operating margin9900€133,898€60,907▼
Operating profit (loss)9901€131,588€58,594▼
Financial income75/76B€1,279€176▼
Recurring financial income75€1,279€176▼
Financial charges65/66B€3,650€251▼
Recurring financial charges65€3,650€251▼
Profit (loss) for the period before taxes9903€129,218€58,519▼
Income taxes67/77€36,198€20,202▼
Profit (loss) for the period9904€93,020€38,317▼
Profit (loss) for the period to be appropriated9905€93,020€38,317▼
Appropriation of the result
Profit (loss) to be appropriated9906€93,020€38,317▼
Transfer to equity691/2€93,020€38,317▼
To other reserves6921€93,020€38,317▼

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20232024Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€494€494=
Other operating charges640/8€1,816€1,818▲ 0.1%
Gross operating margin9900€133,898€60,907▼ 54.5%
Operating profit (loss)9901€131,588€58,594▼ 55.5%
Financial income75/76B€1,279€176▼ 86.3%
Recurring financial income75€1,279€176▼ 86.3%
Financial charges65/66B€3,650€251▼ 93.1%
Recurring financial charges65€3,650€251▼ 93.1%
Profit (loss) for the period before taxes9903€129,218€58,519▼ 54.7%
Income taxes67/77€36,198€20,202▼ 44.2%
Profit (loss) for the period9904€93,020€38,317▼ 58.8%
Profit (loss) for the period to be appropriated9905€93,020€38,317▼ 58.8%
Line20232024Change
Assets
Total assets20/58€130,345€186,918▲ 43.4%
Fixed assets21/28€9,386€8,892▼ 5.3%
Tangible fixed assets22/27€9,386€8,892▼ 5.3%
Plant, machinery and equipment23€9,386€8,892▼ 5.3%
Current assets29/58€120,959€178,026▲ 47.2%
Stocks and contracts in progress3€60,251€55,430▼ 8.0%
Stocks30/36€60,251€55,430▼ 8.0%
Amounts receivable within one year40/41€3,867€23,215▲ 500%
Other amounts receivable41€3,867€23,215▲ 500%
Cash at bank and in hand54/58€56,841€99,380▲ 74.8%
Equity and liabilities
Total equity and liabilities10/49€130,345€186,918▲ 43.4%
Equity10/15€103,020€141,337▲ 37.2%
Contributions10/11€10,000€10,000=
Reserves13€93,020€131,337▲ 41.2%
Distributable reserves133€93,020€131,337▲ 41.2%
Amounts payable17/49€27,325€45,581▲ 66.8%
Amounts payable within one year42/48€27,325€45,581▲ 66.8%
Current portion of amounts payable after more than one year42-€1,714-
Trade debts44€9,927€17,467▲ 75.9%
Suppliers440/4€9,927€17,467▲ 75.9%
Taxes, remuneration and social security45€16,198€26,400▲ 63.0%
Taxes450/3€16,198€26,400▲ 63.0%
Other amounts payable47/48€1,200--
Line20232024Change
Profit (loss) for the period9904€93,020€38,317▼ 58.8%
+ Depreciation and write-downs630€494€494=
Operating cash flow (approximation)€93,514€38,811▼ 58.5%
Investment in fixed assets (approximation)-€0-
Change in cash-€42,540-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
27-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
22-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 22 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wevelgem · 1 establishment unit since 2022
seat establishment The establishment unit on the map
Ground area
1,051 m²
Building footprint
186 m²
Volume, LiDAR
932 m³
Parcel 34029C0646/00H002, Flanders · tallest building 7.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PHARMADIX
Korteweg 5, 8560 WevelgemRetail trade
since 20222.339.263.876
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
34029C0646/00H002 Flanders 1,051 m² 1 · 186 m² 7.0 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Wevelgem2.339.263.876
1 permission
Detailhandel LM>3 maand · since 01-01-2023

Similar companies · same sector, comparable size

Of 2,474 companies in sector 47279 we hold annual accounts for 949. 736 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded16-12-2022
Fiscal year end31-12
Activities, NACEBEL 2025
47279Other retail sale of food
E-invoicing
Reachable via Peppol
Peppol ID 0208:0794868478
Also 9925:BE0794868478
Registered 28-02-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.